Annual Cash & Cash Equivalents
$174.56 M
+$45.68 M+35.44%
31 December 2023
Summary:
Mersana Therapeutics annual cash & cash equivalents is currently $174.56 million, with the most recent change of +$45.68 million (+35.44%) on 31 December 2023. During the last 3 years, it has fallen by -$80.53 million (-31.57%). MRSN annual cash & cash equivalents is now -31.57% below its all-time high of $255.09 million, reached on 31 December 2020.MRSN Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$78.87 M
+$19.87 M+33.68%
30 September 2024
Summary:
Mersana Therapeutics quarterly cash and cash equivalents is currently $78.87 million, with the most recent change of +$19.87 million (+33.68%) on 30 September 2024. Over the past year, it has dropped by -$107.42 million (-57.66%). MRSN quarterly cash and cash equivalents is now -72.65% below its all-time high of $288.38 million, reached on 30 June 2020.MRSN Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRSN Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +35.4% | -57.7% |
| 3 y3 years | -31.6% | -58.9% |
| 5 y5 years | +192.7% | +35.5% |
MRSN Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -31.6% | +35.4% | -65.7% | +33.7% |
| 5 y | 5 years | -31.6% | +192.7% | -72.7% | +35.5% |
| alltime | all time | -31.6% | +1413.5% | -72.7% | +196.6% |
Mersana Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $78.87 M(+33.7%) |
| June 2024 | - | $59.00 M(-21.5%) |
| Mar 2024 | - | $75.19 M(-56.9%) |
| Dec 2023 | $174.56 M(+35.4%) | $174.56 M(-6.3%) |
| Sept 2023 | - | $186.28 M(+44.7%) |
| June 2023 | - | $128.73 M(+4.8%) |
| Mar 2023 | - | $122.83 M(-4.7%) |
| Dec 2022 | $128.88 M(-27.6%) | $128.88 M(-30.0%) |
| Sept 2022 | - | $184.08 M(+36.0%) |
| June 2022 | - | $135.34 M(-41.2%) |
| Mar 2022 | - | $230.06 M(+29.3%) |
| Dec 2021 | $177.95 M(-30.2%) | $177.95 M(-7.2%) |
| Sept 2021 | - | $191.71 M(-15.7%) |
| June 2021 | - | $227.39 M(-0.5%) |
| Mar 2021 | - | $228.43 M(-10.5%) |
| Dec 2020 | $255.09 M | $255.09 M(-5.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2020 | - | $270.94 M(-6.0%) |
| June 2020 | - | $288.38 M(+377.0%) |
| Mar 2020 | - | $60.45 M(-3.0%) |
| Dec 2019 | $62.35 M(+4.6%) | $62.35 M(+7.1%) |
| Sept 2019 | - | $58.20 M(-49.9%) |
| June 2019 | - | $116.21 M(-15.4%) |
| Mar 2019 | - | $137.28 M(+130.2%) |
| Dec 2018 | $59.63 M(+124.3%) | $59.63 M(-3.2%) |
| Sept 2018 | - | $61.60 M(+20.5%) |
| June 2018 | - | $51.14 M(+58.1%) |
| Mar 2018 | - | $32.35 M(+21.7%) |
| Dec 2017 | $26.59 M(-73.5%) | $26.59 M(-47.6%) |
| Sept 2017 | - | $50.76 M(+53.6%) |
| June 2017 | - | $33.05 M(-62.7%) |
| Mar 2017 | - | $88.52 M(-11.7%) |
| Dec 2016 | $100.30 M(+769.6%) | $100.30 M |
| Dec 2015 | $11.53 M | - |
FAQ
- What is Mersana Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Mersana Therapeutics?
- What is Mersana Therapeutics annual cash & cash equivalents year-on-year change?
- What is Mersana Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Mersana Therapeutics?
- What is Mersana Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Mersana Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of MRSN is $174.56 M
What is the all time high annual cash & cash equivalents for Mersana Therapeutics?
Mersana Therapeutics all-time high annual cash & cash equivalents is $255.09 M
What is Mersana Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, MRSN annual cash & cash equivalents has changed by +$45.68 M (+35.44%)
What is Mersana Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of MRSN is $78.87 M
What is the all time high quarterly cash and cash equivalents for Mersana Therapeutics?
Mersana Therapeutics all-time high quarterly cash and cash equivalents is $288.38 M
What is Mersana Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, MRSN quarterly cash and cash equivalents has changed by -$107.42 M (-57.66%)